Theriva Biologics (TOVX) Revenue & Revenue Breakdown
Theriva Biologics Revenue Highlights
Theriva Biologics Revenue by Period
Theriva Biologics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | -100.00% |
| 2010-12-31 | $3.16M | 2969.69% |
| 2009-12-31 | $103.09K | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2007-12-31 | - | 100.00% |
| 2006-12-31 | - | 100.00% |
| 2005-12-31 | - | -100.00% |
| 2002-12-31 | $10.00K | -98.86% |
| 2001-12-31 | $874.10K | 72.55% |
| 2000-12-31 | $506.57K | 26.84% |
| 1999-12-31 | $399.38K | -0.16% |
| 1998-12-31 | $400.00K | -20.00% |
| 1997-12-31 | $500.00K | - |
| 1996-12-31 | $500.00K | 400.00% |
| 1995-12-31 | $100.00K | - |
| 1994-12-31 | $100.00K | - |
| 1993-12-31 | $100.00K | - |
Theriva Biologics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Theriva Biologics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $758.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | -100.00% |
| 2011-12-31 | $-972.12K | -431.31% |
| 2011-09-30 | $293.42K | -17.48% |
| 2011-06-30 | $355.56K | 10.03% |
| 2011-03-31 | $323.14K | -47.85% |
| 2010-12-31 | $619.69K | 113.76% |
| 2010-09-30 | $289.90K | -86.79% |
| 2010-06-30 | $2.19M | 3555.77% |
| 2010-03-31 | $60.04K | 15.45% |
| 2009-12-31 | $52.00K | 1.80% |
| 2009-09-30 | $51.09K | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | - |
Theriva Biologics generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Theriva Biologics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics | $8.01M | - |
| MRKR | Marker Therapeutics | $3.31M | $1.17M |
| PRAX | Praxis Precision Medicines | $2.45M | $357.00K |
| SABS | SAB Biotherapeutics | $2.24M | $263.14K |
| LUMO | Lumos Pharma | $2.05M | $488.00K |
| AVTX | Avalo Therapeutics | $1.41M | - |
| CBIO | Gyre Therapeutics | $794.00K | - |
| VCNX | Vaccinex | $570.00K | $232.00K |
| BDRX | Biodexa Pharmaceuticals | $381.00K | $41.50K |
| XCUR | Exicure | - | - |
| TOVX | Theriva Biologics | - | - |
| LSTA | Lisata Therapeutics | - | - |
| REVB | Revelation Biosciences | - | - |
| KTRA | Kintara Therapeutics | - | - |
| FWBI | Entero Therapeutics | - | - |
| GOVX | GeoVax Labs | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| VRPX | Virpax Pharmaceuticals | - | - |
| PTIX | Protagenic Therapeutics | - | - |
| SLRX | Salarius Pharmaceuticals | - | - |
| DFFN | CervoMed | - | - |
TOVX Revenue FAQ
What is Theriva Biologics’s yearly revenue?
Theriva Biologics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. TOVX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Theriva Biologics’s quarterly revenue?
Theriva Biologics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $758K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). TOVX's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is Theriva Biologics’s revenue growth rate?
Theriva Biologics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.